Skip to main content
Top
Published in: Supportive Care in Cancer 1/2016

01-01-2016 | Erratum

Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer

Authors: Alison T. Stopeck, Karim Fizazi, Jean-Jacques Body, Janet E. Brown, Michael Carducci, Ingo Diel, Yasuhiro Fujiwara, Miguel Martín, Alexander Paterson, Katia Tonkin, Neal Shore, Paul Sieber, Frank Kueppers, Lawrence Karsh, Denise Yardley, Huei Wang, Tapan Maniar, Jorge Arellano, Ada Braun

Published in: Supportive Care in Cancer | Issue 1/2016

Login to get access

Excerpt

Erratum to: Support Care Cancer (2015) …
Metadata
Title
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer
Authors
Alison T. Stopeck
Karim Fizazi
Jean-Jacques Body
Janet E. Brown
Michael Carducci
Ingo Diel
Yasuhiro Fujiwara
Miguel Martín
Alexander Paterson
Katia Tonkin
Neal Shore
Paul Sieber
Frank Kueppers
Lawrence Karsh
Denise Yardley
Huei Wang
Tapan Maniar
Jorge Arellano
Ada Braun
Publication date
01-01-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 1/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2985-1

Other articles of this Issue 1/2016

Supportive Care in Cancer 1/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine